Skip to content

Trial Summary

The Multi-Arm GlioblastoMa Australasia (MAGMA) Trial is a platform trial that will assess a number of options in standard of care for the management of glioblastoma.



ACTRN/NCT /ethics:


Scientific title:

A multi-arm multi-stage, multi-centre, phase III (MAMS) platform trial that aims to assess hypotheses against a common standard-of-care control arm for the management of people with glioblastoma.

Sponsor / Cooperative group:

Medical Research Future Fund

Trial & Patient Characteristics

Cancer TypeBrain & central nervous system
Trial TypeTreatment
PhasePhase II
Age Range18 years and older
Tumour Stream -
Cancer StageAll stages
Anticipated Start Date2020-09-15
Anticipated End Date2023-06-30

Participating Hospitals

HospitalFlinders Medical Centre
Clinical Trial CoordinatorAlison Richards
Phone08 8206 4835
Principal InvestigatorDr Anna Mislang
Recruitment StatusRecruiting